uPA Binding to PAI-1 Induces Corneal Myofibroblast Differentiation on Vitronectin

被引:14
|
作者
Wang, Lingyan [1 ]
Ly, Christine M. [1 ]
Ko, Chun-Ying [1 ]
Meyers, Erin E. [1 ]
Lawrence, Daniel A. [2 ]
Bernstein, Audrey M. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; GROWTH-FACTOR; TISSUE-REPAIR; TGF-BETA; IN-VIVO; EXTRACELLULAR-MATRIX; CELL ADHESION; FIBROSIS; FIBROBLASTS; MECHANISMS;
D O I
10.1167/iovs.12-10042
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Vitronectin (VN) in provisional extracellular matrix (ECM) promotes cell migration. Fibrotic ECM also includes VN and, paradoxically, strongly adherent myofibroblasts (Mfs). Because fibrotic Mfs secrete elevated amounts of urokinase plasminogen activator (uPA), we tested whether increased extracellular uPA promotes the persistence of Mfs on VN. METHODS. Primary human corneal fibroblasts (HCFs) were cultured in supplemented serum-free medium on VN or collagen (CL) with 1ng/mL transforming growth factor beta 1 (TGF beta 1). Adherent cells were quantified using crystal violet. Protein expression was measured by Western blotting and flow cytometry. Transfection of short interfering RNAs was performed by nucleofection. Mfs were identified by alpha-smooth muscle actin (alpha-SMA) stress fibers. Plasminogen activator inhibitor (PAI-1) levels were quantified by ELISA. RESULTS. TGF beta 1-treated HCFs secreted PAI-1 (0.5uM) that bound to VN, competing with alpha v beta 3/alpha v beta 5 integrin/VN binding, thus promoting cell detachment from VN. However, addition of uPA to cells on VN increased Mf differentiation (9.7-fold), cell-adhesion (2.2-fold), and binding by the VN integrins alpha v beta 3 and -beta 5 (2.2-fold). Plasmin activity was not involved in promoting these changes, as treatment with the plasmin inhibitor aprotinin had no effect. A dominant negative PAI-1 mutant (PAI-1R) that binds to VN but does not inhibit uPA prevented the increase in uPA-stimulated cell adhesion and reduced uPA-stimulated integrin alpha v beta 3/alpha v beta 5 binding to VN by 73%. CONCLUSIONS. uPA induction of TGF beta 1-dependent Mf differentiation on VN supports the hypothesis that elevated secretion of uPA in fibrotic tissue may promote cell adhesion and the persistence of Mfs. By blocking uPA-stimulated cell adhesion, PAI-1R may be a useful agent in combating corneal scarring. (Invest Ophthalmol Vis Sci. 2012;53:4765-4775) DOI: 10.1167/iovs.12-10042
引用
收藏
页码:4765 / 4775
页数:11
相关论文
共 50 条
  • [41] How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
    Zhou, AW
    Huntington, JA
    Pannu, NS
    Carrell, RW
    Read, RJ
    NATURE STRUCTURAL BIOLOGY, 2003, 10 (07) : 541 - 544
  • [42] INFLUENCE OF THE DETERGENT TWEEN 80 ON THE ACTIVITY OF PAI-1 AND PROTECTION BY VITRONECTIN
    BJORQUIST, P
    EHNEBOM, J
    KRISTIANSEN, C
    DEINUM, J
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1009 - 1009
  • [43] How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
    Aiwu Zhou
    James A Huntington
    Navraj S Pannu
    Robin W Carrell
    Randy J Read
    Nature Structural & Molecular Biology, 2003, 10 : 541 - 544
  • [44] Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors
    Kumamoto, H.
    Ooya, K.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2007, 36 (08) : 488 - 494
  • [45] DRL performance in mice with deletion of tPA, uPA or PAI-1 genes
    Horwood, JM
    Ripley, TL
    Stephens, DN
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (6-7): : 487 - 496
  • [46] Prognostic factors uPA/PAI-1: measurement in core needle biopsies
    Vetter, M.
    Landstorfer, B.
    Lantzsch, T.
    Buchmann, J.
    Grosse, R.
    Ruschke, K.
    Holzhausen, H-J
    Thomssen, C.
    Kantelhardt, E-J
    CANCER RESEARCH, 2012, 72
  • [47] Prognostic and predictive impact of uPA/PAI-1 in early breast cancer
    Wieder, V.
    Engel, J.
    Bauer, M.
    Kaufhold, S.
    Hanf, V.
    Uleer, C.
    Lantzsch, T.
    Peschel, S.
    John, J.
    Poehler, M.
    Weigert, E.
    Burrig, K-F.
    Buchmann, J.
    Kantelhardt, E.
    Thomssen, C.
    Vetter, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S297 - S297
  • [48] The value of uPA and PAI-1 levels in triple negative breast cancer
    Sobocan, M.
    Ledinek, Z.
    Crnobrnja, B.
    Sikosek, N. Cas
    Dovnik, N. Fokter
    Kavalar, R.
    Knez, J.
    Takac, I.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S73 - S74
  • [49] High levels of uPA and PAI-1 predict a good response to anthracyclines
    Kathleen I. Pritchard
    Breast Cancer Research and Treatment, 2010, 121 : 625 - 626
  • [50] Quantitative protein network monitoring for uPA and PAI-1 in breast cancer
    Malinowsky, K.
    Boellner, C.
    Berg, D.
    Walch, A.
    Schuster, T.
    Schmitt, M.
    Becker, K. -F.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 172 - 172